Published in J Immunol Methods on October 14, 1983
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A (1997) 2.44
Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J Exp Med (1995) 2.13
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin Diagn Lab Immunol (1998) 1.93
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol (2006) 1.91
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun (1994) 1.38
DegS is necessary for virulence and is among extraintestinal Escherichia coli genes induced in murine peritonitis. Infect Immun (2003) 1.28
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. J Virol (2006) 1.17
The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. Immunology (1986) 1.04
A family with complement factor D deficiency. J Clin Invest (2001) 1.00
Inhibition of human complement by beta-glycyrrhetinic acid. Immunology (1997) 0.98
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc Natl Acad Sci U S A (1992) 0.97
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation. Infect Immun (2000) 0.93
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J Virol (1988) 0.92
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden. Haematologica (2011) 0.88
Sex-limited protein: in vitro and in vivo functions. Clin Exp Immunol (1999) 0.80
Structural analysis and anti-complement activity of polysaccharides from Kjellmaniella crsaaifolia. Mar Drugs (2015) 0.77
Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice. Immunology (1991) 0.76
Effects of pectic polysaccharides isolated from leek on the production of reactive oxygen and nitrogen species by phagocytes. J Med Food (2013) 0.76
The Structure-Activity Relationship between Marine Algae Polysaccharides and Anti-Complement Activity. Mar Drugs (2015) 0.76
Increased local complement levels upon intraperitoneal injection of mice with Listeria monocytogenes and regulation by polyanions. Infect Immun (1985) 0.75
Trichosanthin, an initiator of the alternative complement activation pathway. Clin Exp Immunol (1993) 0.75
Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann Immunol (Paris) (1974) 2.38
Optical performance of multifocal intraocular lenses. J Cataract Refract Surg (1990) 1.74
Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med (1990) 1.68
PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist (1997) 1.67
Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse. Immunology (1977) 1.52
Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice. Immunology (1977) 1.51
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen. Immunology (1979) 1.47
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun (1994) 1.38
Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions. Nature (1977) 1.34
Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol (2001) 1.23
Transformation of type polysaccharide antigen synthesis and hemolysin synthesis in streptococci. J Bacteriol (1968) 1.22
Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3. Infect Immun (1983) 1.21
The influence of cyclophosphamide on antibody formation in the mouse. Ann Immunol (Paris) (1975) 1.18
A semi-electronic device for measuring delayed hypersensitivity in the mouse by footpad swelling. J Immunol Methods (1976) 1.16
Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria. Clin Exp Immunol (1979) 1.15
Identification of RFLP markers closely linked to the bolting gene B and their significance for the study of the annual habit in beets (Beta vulgaris L.). Theor Appl Genet (1994) 1.14
Loss of type antigen in a type 3 streptococcus and identification of the determinant disaccharide of the remaining antigen. J Gen Microbiol (1967) 1.14
Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes. J Immunol Methods (1980) 1.12
An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey. J Wound Care (2008) 1.09
In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods (1991) 1.09
Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents (2001) 1.06
Cells involved in the graft-versus-host reaction in vitro. Immunology (1973) 1.06
Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol (2000) 1.04
Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity. Int Arch Allergy Appl Immunol (1981) 1.02
Immunochemistry of the carbohydrate antigens of some Streptococcus salivarius strains. J Gen Microbiol (1971) 1.02
The role of Peyer's patch cells in antibody formation. Immunology (1973) 1.01
Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology (Oxford) (1999) 1.01
Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3. Infect Immun (1983) 1.01
Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes. J Immunol Methods (1980) 0.99
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. II. Induction of delayed-type hypersensitivity. Immunology (1981) 0.99
Inhibition of human complement by beta-glycyrrhetinic acid. Immunology (1997) 0.98
Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora. J Ethnopharmacol (2000) 0.98
The linkage disequilibrium between chloroplast DNA and mitochondrial DNA haplotypes in Beta vulgaris ssp. maritima (L.): the usefulness of both genomes for population genetic studies. Mol Ecol (2000) 0.98
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc Natl Acad Sci U S A (1992) 0.97
The origin and evolution of weed beets: consequences for the breeding and release of herbicide-resistant transgenic sugar beets. Theor Appl Genet (1993) 0.96
New, simple medium for selective recovery of Klebsiella pneumoniae and Klebsiella oxytoca from human feces. J Clin Microbiol (1984) 0.96
Interactions of killed Listeria monocytogenes with the mouse complement system. Infect Immun (1981) 0.96
Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants. Immunology (1979) 0.95
Rapid isolation and characterization of native mouse complement components C3 and C5. J Immunol Methods (1989) 0.95
Distribution of different cell types in the lymphoid organs of the mouse, as determined with sera against thymus and Peyer's patches. Immunology (1974) 0.94
Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline. Clin Exp Immunol (1979) 0.94
Effects of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation. Cell Immunol (1977) 0.93
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity. Immunology (1981) 0.93
Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide. Infect Immun (1985) 0.93
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol (1995) 0.92
Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology (2000) 0.92
Cellular and humoral adjuvant activity of mistletoe extract. Immunobiology (1979) 0.92
Killed Listeria monocytogenes vaccine is protective in C3H/HeJ mice without addition of adjuvants. Nature (1980) 0.92
Immunomodulating properties of two synthetic adjuvants: dependence upon type of antigen, dose, and time of administration. Cell Immunol (1984) 0.91
Curcacycline A--a novel cyclic octapeptide isolated from the latex of Jatropha curcas L. FEBS Lett (1995) 0.90
Hamilton's rule, imprinting and parent-offspring conflict over seed mass in partially selfing plants. J Evol Biol (2005) 0.89
The selective localization of B lymphocytes in the spleen and the role of complement receptors. Eur J Immunol (1985) 0.89
Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of fiber type and age. Am J Physiol (1993) 0.88
Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response. J Immunol (1987) 0.88
Effects of lactobacilli on parameters of non-specific resistance of mice. Med Microbiol Immunol (1981) 0.88
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice. Immunology (1982) 0.87
A one-step isolation procedure for phospholipase A2-free cobra venom factor by fast protein liquid chromatography. J Immunol Methods (1987) 0.86
Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells. Int Arch Allergy Appl Immunol (1973) 0.86
Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques. J Immunol Methods (1988) 0.86
Immunomodulatory activity of an aqueous extract of Azadirachta indica stem bark. J Ethnopharmacol (1987) 0.85
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J Infect Dis (1996) 0.85
How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophils. Chem Biol Interact (1990) 0.85
Stimulation of the immune response against SRBC by reduction of corticosterone plasma levels: mediation by mononuclear phagocytes. Cell Immunol (1976) 0.85
Bacteriophage MS-2 in the immune response. Int Arch Allergy Appl Immunol (1976) 0.85
Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity. J Pathol (1989) 0.84
Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes. Infect Immun (1996) 0.84
Development of a simple passive haemagglutination-inhibition assay for Listeria monocytogenes lipoteichoic acid. J Immunol Methods (1981) 0.84
Effects of cyclophosphamide treatment on the in vitro activity of mouse lymphoid cells after nonspecific and specific stimulation. Int Arch Allergy Appl Immunol (1976) 0.84
Glycolipids from the cell walls of Streptococci. Antonie Van Leeuwenhoek (1973) 0.83
Electron microscopic observations on the interaction of Listeria monocytogenes and peritoneal macrophages of normal mice. Lab Invest (1980) 0.83
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. Immunology (1981) 0.83
Oxisuran and immune reactions: mediation of oxisuran action by the adrenal glands. J Immunol (1975) 0.83
Influence on macrophage functions as a possible basis of immunomodification by polyanions. Ann Immunol (Paris) (1981) 0.83
Inhibition of T-lymphocyte proliferation by cucurbitacins from Picrorhiza scrophulariaeflora. J Nat Prod (2000) 0.83
Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates. Infect Immun (1989) 0.82
Effects of dimethyldioctadecylammonium bromide on phagocytosis and digestion of Listeria monocytogenes by mouse peritoneal macrophages. Immunology (1981) 0.82
Metabolic and antioxidant enzyme activities in the diaphragm: effects of acute exercise. Respir Physiol (1994) 0.82
Regulation of the immune response by macrophages. Antonie Van Leeuwenhoek (1979) 0.82
Effect of in vivo administration of different adjuvants on the in vitro candidacidal activity of mouse peritoneal cells. Cell Immunol (1985) 0.82
A novel formulation of metal ions and citric acid reduces reactive oxygen species in vitro. J Wound Care (2003) 0.81
Effects of immunological adjuvants on the mouse complement system. I. The inability of the polyanion heparin to act as an adjuvant is paralleled by inefficient alternative complement pathway inhibition. Int J Immunopharmacol (1983) 0.81
Delayed-type hypersensitivity in rabbits. Comparison of the adjuvants dimethyl dioctadecyl ammonium bromide and Freund's complete adjuvant. Int Arch Allergy Appl Immunol (1982) 0.81
Activity-guided isolation and identification of Azadirachta indica bark extract constituents which specifically inhibit chemiluminescence production by activated human polymorphonuclear leukocytes. Planta Med (1991) 0.81
Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines. Infect Immun (1988) 0.81
Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis). Immunology (1978) 0.80
Sex-limited protein: in vitro and in vivo functions. Clin Exp Immunol (1999) 0.80
Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response. Cell Immunol (1985) 0.80
Moraxella catarrhalis in acute laryngitis: infection or colonization? J Infect Dis (1996) 0.80
Simple sugars with affinity for the macrophage asialoglycoprotein receptor are adjuvants for the humoral immune response to neuraminidase-treated sheep erythrocytes. J Immunol (1986) 0.79
Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system. J Immunol Methods (1990) 0.79